Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,316 public trials 525 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

NCT02515474

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Choledocholithiasis, +7 more
Locations
  • The first hospital of Lanzhou University Lanzhou, Gansu, China
  • Union hospital,Tongji medical collage,Huazhong University of science and technology Wuhan, Hubei, China
  • Second Xiangya Hospital, Central South University Changsha, Hunan, China
  • The First Hospital of Jilin University Changchun, Jilin, China
View Trial Details
Completed

Post-resection Treatment of Large Colon Polyps

NCT03654209

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +1 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Indiana University Health University Hospital Indianapolis, Indiana, United States
  • Spring Mill Medical Center Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02600897

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta, Georgia, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Missouri/Ellis Fischel Columbia, Missouri, United States
  • Washington University; Wash Uni. Sch. Of Med St Louis, Missouri, United States
View all 28 locations
View Trial Details
Completed

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

NCT04405349

Conditions
Cervical Cancer, Cervix Cancer, Disease Attributes, +18 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Hopital de Libramont Brussels, Belgium
  • Universitair Ziekenhuis Gent (Uz Gent) Ghent, Belgium
  • Chu Ucl Namur Namur, Belgium
View all 21 locations
View Trial Details
Completed

BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA)

NCT02834364

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations
  • Universitätsklinikum Köln, Klinik I Innere Medizin Cologne, Germany
  • Mediz. Klinik und Poliklinik 1, Universitätsklinikum Dresden Dresden, Germany
  • Universitätsklinikum Frankfurt, Medizinische Klinik II Frankfurt am Main, Germany
  • University Hospital Heidelberg, Med. Klinik V Heidelberg, Germany
View Trial Details
Completed

A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma

NCT04187352

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Hefei Second People's Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
View all 72 locations
View Trial Details

Related conditions